This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Sep;160(3):811-812.

doi: 10.1016/j.chest.2021.04.045.

Rebuttal From Dr Bates

Clive D Bates¹

Affiliations

PMID: 34488960
DOI: 10.1016/j.chest.2021.04.045

Editorial

Rebuttal From Dr Bates

Clive D Bates. Chest. 2021 Sep.

. 2021 Sep;160(3):811-812.

doi: 10.1016/j.chest.2021.04.045.

Author

Clive D Bates¹

Affiliation

¹ Counterfactual Consulting Limited, London, England. Electronic address: clivdbates@gmail.com.

PMID: 34488960
DOI: 10.1016/j.chest.2021.04.045

No abstract available

PubMed Disclaimer

Comment in

Rebuttal From Drs Kathuria and Leone.
Kathuria H, Leone FT. Kathuria H, et al. Chest. 2021 Sep;160(3):812-813. doi: 10.1016/j.chest.2021.04.047. Chest. 2021. PMID: 34488961 No abstract available.

Comment on

POINT: e-Cigarette Use for Harm Reduction in Tobacco Use Disorder? Yes.
Bates CD. Bates CD. Chest. 2021 Sep;160(3):807-809. doi: 10.1016/j.chest.2021.04.046. Chest. 2021. PMID: 34488958 No abstract available.
COUNTERPOINT: e-Cigarette Use for Harm Reduction in Tobacco Use Disorder? No.
Kathuria H, Leone FT. Kathuria H, et al. Chest. 2021 Sep;160(3):809-811. doi: 10.1016/j.chest.2021.04.044. Chest. 2021. PMID: 34488959 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources